RISER Meet and Greet - Phase II

Amendment 2 is to extend the due date for small business interest. The tentative December 11, 2024 date for the meet and greet is no longer valid a new date will be set after Phase II closes on December 16, 2024. More information will be provided once Phase II closes and the Zoom link is provided. This announcement is not a solicitation. This announcement does not constitute an invitation for bid, request for proposal, or request for quotation and is not to be construed as a commitment by the government.

This is for informational purposes only; the government will not reimburse any costs associated with attending the meet and greet. The CDC is seeking interested large businesses under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing with the current capabilities to provide the services outlined in the attached Performance Work Statement (PWS). The intent of this announcement is to obtain a list of qualified large businesses that would be interested in providing proposals for the attached PWS.

The CDC will publish the list of interested large businesses and ask for interested small businesses who could potentially provide services via subcontracts. CDC will then provide a Zoom conference line that will allow businesses to meet to begin to establish a relationship. Do not provide a proposal for this requirement; the CDC is only asking for the information listed below in the announcement at this point.

This announcement is phase one in a three-phase process that will be accomplished by the publication of this announcement and by amending it for future phases. Below is a summary of the phases: Phase I – call for interested large businesses. Phase II – publish information received from large businesses and initiate call for interested small businesses. Phase III – provide the link and finalized dates/times for the virtual meet and greet once the final number of large and small businesses is known.